drugset / Trial / NCT01736514
A Study to Evaluate Safety and Efficacy of Oral Febuxostat in Patients With Gout
RandomizedParallel-groupOpen-labelTreatment
Summary
This is a multicenter, open label, randomized, allopurinol-controlled, parallel-design study. Approximately 120 subjects will be randomly assigned in 1:1 ratio to receive febuxostat, or allopurinol for subjects with gout.
Timeline
- Start
- 2011-03
- Primary completion
- 2012-02
- Completion
- 2012-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Allopurinol | Small molecule | — | Oral |
| Subject | Febuxostat | Small molecule | — | Oral |